Publication | Open Access

Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study

PsychiatryOpen-label StudyDepressionSocial SciencesClinical BenefitNeurologyTranscranial Magnetic StimulationBrain StimulationMental HealthNeurostimulationMedicineCognitive TherapyRelapse PreventionPsychopathology